In this context, our observation that high CARD14 expression in PCa patients correlates with more aggressive PCa, together with the finding that CARD14 expression is essential for survival of LNCaP PCa cells, reveal CARD14 as a novel anti-cancer target in PCa. Here, CARD14 is linked to posterior cortical atrophy.